KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Parsons (PSN) Asset Writedowns and Impairment (2018 - 2023)

Parsons (PSN) has disclosed Asset Writedowns and Impairment for 6 consecutive years, with -$59000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Asset Writedowns and Impairment fell 198.33% to -$59000.0 in Q4 2023 year-over-year; TTM through Dec 2024 was -$59000.0, a 284.38% decrease, with the full-year FY2023 number at $32000.0, down 43.86% from a year prior.
  • Asset Writedowns and Impairment was -$59000.0 for Q4 2023 at Parsons, down from $91000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.3 million in Q4 2019 to a low of -$1.6 million in Q4 2020.
  • A 5-year average of -$93000.0 and a median of $2500.0 in 2021 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: soared 132.66% in 2019, then crashed 224.16% in 2020.
  • Parsons' Asset Writedowns and Impairment stood at $1.3 million in 2019, then plummeted by 224.16% to -$1.6 million in 2020, then skyrocketed by 100.51% to $8000.0 in 2021, then skyrocketed by 650.0% to $60000.0 in 2022, then tumbled by 198.33% to -$59000.0 in 2023.
  • Per Business Quant, the three most recent readings for PSN's Asset Writedowns and Impairment are -$59000.0 (Q4 2023), $91000.0 (Q2 2023), and $60000.0 (Q4 2022).